Ella Daniels

Medical Oncology SpR | RCP Chief Registrar | ACP trainee committee member. Interests: global health, education, gin. Weakness: remembering to actually tweet

[Ella Daniels @ellarose146]

Over and out from #acp24 - excellent couple of days! Looking forward to 2025 already

[Ella Daniels @ellarose146]

Dr Kai Keen Shiu discussing drugging the undruggable KRAS mutant metastatic CRC #acp24

[Ella Daniels @ellarose146]

Dr Heather Shaw talking about making the hammer of immunotherapy more precise #acp24

[Ella Daniels @ellarose146]

@drmaiseb presenting on the recent revolutionary CAR-T trials in solid organ cancers #acp24

[Ella Daniels @ellarose146]

ACP 2024 Bagshawe lecture - Professor Carlos Caldas discussing the current landscape of whole genome sequencing in cancer care #acp24

[Ella Daniels @ellarose146]

Great talk from Dr Caroline Michie on tailoring breast cancer treatments based on pathological response #acp24

[Ella Daniels @ellarose146]

An honour to have the fabulous @RickyFrazer1 talking to us after dinner last night about mentorship, compassionate leadership and finding your why #acp24

[Ella Daniels @ellarose146]

Dr Karin Purshouse from @onctrainees giving us an overview of what NOTCH is about - keen for more ACP/NOTCH collaboration in the future! #acp24

[Ella Daniels @ellarose146]

Dr Rebecca Lee discussing the "Achilles heel" of cancer adaptive treatment and where ctDNA fits in #acp24

[Ella Daniels @ellarose146]

Professor Chris Twelves teaching on the heterogeneity of triple negative breast cancer and emerging targets #acp24

[Ella Daniels @ellarose146]

@AdamJanuszewski breaking down the complexity of the lung cancer molecular landscape #acp24

[Ella Daniels @ellarose146]

Finishing the renal session on the importance of gut microbiome and treatment response - an exciting space for the future? #acp24

[Ella Daniels @ellarose146]

Next up - Dr Naveen Vasudev talking about the "oxymoron" of precision oncology in renal cancers #acp24

[Ella Daniels @ellarose146]

Hearing about the MIRASOL study and that mirvetuximab is the first recent drug to show an OS benefit in platinum-resistant high grade ovarian cancer #acp24

[Ella Daniels @ellarose146]

Dr Rowan Miller discussing the imperfections of HRD testing in ovarian cancer #acp24

[Ella Daniels @ellarose146]

Excellent start to the meeting from the Cancer Vaccine Launchpad Team - Dr Dan Muller highlighting the #associatepi scheme as a way of med onc trainees becoming involved #acp24 #nihr

[Ella Daniels @ellarose146]

Resurrecting my twitter account for #ACP24 @ACPUK !